LACY ESTES: Open Payments
NPI 1275148967 · BELMONT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 17 payments from 4 companies in 2025. Trend: 2023 $158 · 2024 $360 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, AIRSUPRA, Ozempic, QULIPTA, LINZESS.
Industry payments across MS — which companies pay providers there.
